PAP

Persistent Asset Partners Portfolio holdings

AUM $208M
1-Year Est. Return 95.31%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+95.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$208M
AUM Growth
+$70M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
392
New
Increased
Reduced
Closed

Top Buys

1
+$8.43M
2
+$5.15M
3
+$4.26M
4
SNDK
Sandisk
SNDK
+$3.61M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.5M

Top Sells

1
+$4.82M
2
+$3.15M
3
+$2.87M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.84M
5
LH icon
Labcorp
LH
+$2.58M

Sector Composition

1 Healthcare 56.04%
2 Technology 14.52%
3 Financials 12.06%
4 Communication Services 4.8%
5 Energy 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LQDA icon
151
Liquidia Corp
LQDA
$3.48B
$363K 0.17%
+10,536
SNY icon
152
Sanofi
SNY
$115B
$361K 0.17%
+7,445
XERS icon
153
Xeris Biopharma Holdings
XERS
$1.1B
$358K 0.17%
45,609
+28,407
ARDX icon
154
Ardelyx
ARDX
$1.58B
$353K 0.17%
60,490
-31,556
GLUE icon
155
Monte Rosa Therapeutics
GLUE
$1.58B
$348K 0.17%
+22,211
SLNO icon
156
Soleno Therapeutics
SLNO
$2.73B
$343K 0.17%
7,416
-33,843
RIGL icon
157
Rigel Pharmaceuticals
RIGL
$599M
$342K 0.16%
+7,995
NTRA icon
158
Natera
NTRA
$29.5B
$340K 0.16%
+1,484
WVE icon
159
Wave Life Sciences
WVE
$1.41B
$337K 0.16%
+19,827
PCRX icon
160
Pacira BioSciences
PCRX
$1B
$335K 0.16%
12,962
-613
DSGN icon
161
Design Therapeutics
DSGN
$809M
$328K 0.16%
+34,989
JAZZ icon
162
Jazz Pharmaceuticals
JAZZ
$12.5B
$321K 0.15%
1,891
-3,385
ITGR icon
163
Integer Holdings
ITGR
$3.07B
$320K 0.15%
+4,075
NPB
164
Northpointe Bancshares
NPB
$662M
$314K 0.15%
18,711
-23,019
PFSI icon
165
PennyMac Financial
PFSI
$4.93B
$308K 0.15%
+2,339
CMPX icon
166
Compass Therapeutics
CMPX
$1.08B
$307K 0.15%
+57,253
ROIV icon
167
Roivant Sciences
ROIV
$21.3B
$306K 0.15%
14,121
-13,546
URGN icon
168
UroGen Pharma
URGN
$1.1B
$300K 0.14%
12,806
-7,920
U icon
169
Unity
U
$11.3B
$297K 0.14%
+6,734
OCUL icon
170
Ocular Therapeutix
OCUL
$2.14B
$291K 0.14%
+23,984
BNTC icon
171
Benitec Biopharma
BNTC
$484M
$280K 0.13%
+20,753
FBRX icon
172
Forte Biosciences
FBRX
$665M
$277K 0.13%
+10,146
ENTA icon
173
Enanta Pharmaceuticals
ENTA
$407M
$275K 0.13%
+17,466
AVTX icon
174
Avalo Therapeutics
AVTX
$329M
$274K 0.13%
+15,087
MAZE
175
Maze Therapeutics
MAZE
$1.4B
$274K 0.13%
+6,605
5 6
7
8 9